Our news predictions for 2017
Climate change continues to impact on public health Despite what many commenters have said in 2016, climate change is real and is ongoing. That's the thing about science. Just because you don't believe in it, it doesn't go away. In 2016 we have seen evidence of the impact of climate change in a number of different ways. There was an anthrax outbreak in northern Russia as warm weather caused the release of previously frozen deadly anthrax spores. And many experts think that the spread of the Zika virus across much of the Americas was made possible, in part, by changes in temperature that created environments in which the A. aegypti mosquito could survive. It is hard to predict what further effects could occur in 2017. One possibility is that changes to the seasonal temperature in England could increase the length of the "pollen season", increasing the misery for allergy sufferers in this country. HIV vaccine is proven to work There is a real possibility that a vaccine that prevents HIV from taking hold of a person’s immune system could be proven to be effective in 2017. The vaccine – known as SAV001 – is designed to work by exposing the immune system to a safe, "deactivated" form of the virus. This then "teaches" the immune system to produce antibodies that can fight HIV. Phase 2 trials – involving around 300 people – in order to see if the vaccine works as hoped are planned for 2017. Virtual reality triggers ...
British Prime Minister Boris Johnson was in intensive care on Tuesday after receiving oxygen support for serious COVID-19 complications, leaving his foreign minister to lead the government's response to the accelerating outbreak.
If you’re staying shut in your home, anxious about when you will finally be able to take a stroll outside or whether you or someone close to you will be infected by the novel coronavirus, you are not the only one. In the U.S. alone, half of the adults report high levels of anxiety due to the COVID-19, according to the American Psychiatric Association. The ongoing pandemic is exerting the whole world both physically and mentally. One thing is sure to be asked by everyone: when will all this be over? Some think that things will never get back to normal. Acclaimed sci-fi writer Ted Chiang says that “we do...
The aim of the study was to determine the association between pet ownership and cardiovascular risk factors and mortality. Electronic search was conducted through nine databases including PubMed for relevant publications reporting cardiovascular events and mortality among pet owners. Meta-analysis was used to pool the results. Of a total of 2818 reports screened, 26 studies were included in our systematic review and meta-analysis. Higher survival rate was observed in the pet owners group after pooling nonadjusted and adjusted hazard ratios for cardiovascular mortality at 0.73 [95% confidence interval (CI) 0.62–0.86] ...
British Prime Minister Boris Johnson is still in intensive care but his team are working together to fight the coronavirus outbreak, Cabinet Office Minister Michael Gove said on Tuesday.
The governors of New York, New Jersey and Louisiana pointed to tentative signs on Monday that the coronavirus outbreak may be starting to plateau in their states but warned against complacency as the death toll nationwide approached 11,000.
This report highlights some of the knowledge shared at the SPSASV.
Gov. Andrew Cuomo warned that glimmers of hope could continue only if New Yorkers maintain discipline and suppress an impulse to gather.
A simple plan to stop a coronavirus outbreak among homeless people has gotten complicated, now that a worker was hurt emptying a hand-washing station.
It is estimated that the three private clinic networks - Rutherford Health, Genesis Care and HCA UK - could treat an estimated 5,000 patients per month.
Publication date: Available online 6 April 2020Source: Journal of Molecular StructureAuthor(s): Saravanan Kandasamy, Prabhu Subramani, Selvi Subramani, John marshal Jayaraj, Gunasekaran Prasanth, Kannupal Srinivasan, Karthikeyan Muthusamy, Venkatachalam Rajakannan, Ravikumar Vilwanathan
More News: Allergy | Allergy & Immunology | Anthrax | Anthrax Vaccine | Breast Cancer | Cancer | Cancer & Oncology | Cancer Vaccines | Chemotherapy | Environmental Health | Funding | Girls | Health | International Medicine & Public Health | Outbreaks | Phobias | Podcasts | Research | Science | Teaching | Training | Universities & Medical Training | Vaccines | Websites | Zika Virus